This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2022
Title: Pavel Alekseevich Grebnev and His Biotechnology Patent.
Introduction
Pavel Alekseevich Grebnev is an inventor associated with Ust'-Ilimsk, Irkutsk Oblast, Russia. His recorded patent concerns biotechnology and the development of antibodies targeting PD-L1.
Latest Patents
Grebnev is listed as an inventor on 1 patent, titled “Monoclonal Antibody to PD-L1.” The invention describes antibodies that specifically bind to PD-L1. It also covers DNA encoding the antibodies, corresponding expression vectors, methods for producing them, and potential treatment methods using the antibodies.
Career Highlights
The patent reflects work in biotechnology, particularly antibody development and its possible therapeutic applications. The available information does not identify an employer, so no company affiliation is included.
Collaborations
Grebnev’s listed coworkers include Dmitry Valentinovich Morozov and Viktoriia Mikhailovna Ekimova. Their names appear alongside his in connection with the patent information provided.
Conclusion
Pavel Alekseevich Grebnev’s recorded contribution is a biotechnology patent focused on PD-L1-binding antibodies and related production and treatment methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile